RoosterBio Headquarters in Frederick, MD

Our team has been working diligently this year to grow our customer base across the globe, now shipping to 26 countries and the need to expand our facility is a result of the industry validating our value proposition.

FREDERICK, Md. (PRWEB)
December 18, 2019

RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess systems, announces today an expansion of its facility in Frederick, Maryland for the second time in 2019. The addition of 5,000 square feet to its existing 15,500 footprint supports the company’s expansion efforts and provides infrastructure to meet a growing international demand for its standardized hMSC bioprocess tools. By strengthening its cell manufacturing solution portfolio and presence in the Asia Pacific and Europe, RoosterBio is giving more people around the world the ability to advance regenerative medicine cures.

RoosterBio’s headquarters at The Offices at Westview serves as a center of excellence, incorporating the latest scale up bioprocessing technology and allows the company to quality test its cells and media in a variety of conditions and applications. The new space will increase shipping capabilities for a growing international network by the end of the year. RoosterBio announced the first expansion of its facility earlier this year which served as a catalyst for its strategic international growth initiatives. The company plans to launch an international presence in Asia during the first half of 2020.

“Our team has been working diligently this year to grow our customer base across the globe, now shipping to 26 countries and the need to expand our facility is a result of the industry validating our value proposition,” said RoosterBio’s Chief Executive Officer Margot Connor. “As our efforts have increased, we’ve increased our employee base by nearly 30% this year and we’re excited about our continued annual growth rate.” Connor added, “We’re taking RoosterBio to the next level in the international hMSC marketplace.”

These enhancements build on RoosterBio’s proven track record of industrializing the supply chain for the new field of regenerative medicine. The products that RoosterBio has commercialized are designed to standardize hMSC manufacturing with consistent cGMP product offerings, removing years of time, and millions of dollars, from traditional mesenchymal cell therapeutic product development and clinical translation efforts. RoosterBio will also be launching a cGMP version of its extracellular vesicle production tools in early 2020.

About RoosterBio, Inc

RoosterBio, Inc. is a privately held cell manufacturing platform technology company focused on accelerating the development of a sustainable regenerative medicine industry, one customer at a time. RoosterBio’s products are high volume, affordable, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. RoosterBio’s innovative products are ushering in a new era of productivity and standardization to the field, accelerating the road to discovery in Regenerative Medicine. For more information on RoosterBio, please visit http://www.roosterbio.com.

Share article on social media or email:

“Students will develop a deep understanding of business problems and the analytics skills to make informed, data-driven strategic decisions.”

CHAPEL HILL, N.C. (PRWEB)
December 18, 2019

The University of North Carolina Kenan-Flagler Business School will offer a new concentration in business analytics and management science in its full-time MBA Program that is STEM designated.

UNC Kenan-Flagler will start offering the business analytics and management science concentration in in January 2020.

“Our focus is on strategic decision-making to prepare our graduates to use analytics to lead companies,” said Rajdeep Grewal, the Townsend Family Distinguished Professor of Marketing and a concentration leader.

“Today managers are inundated with data that comes in large volume at immense velocity and in diverse, structured and unstructured forms,” he said. “Through the concentration, our students will develop a deep understanding of business problems and the analytics skills to make informed, data-driven strategic decisions.”

“Courses build the data analytic toolkit for business applications and business acumen to apply and refine them for a diverse set of business functions,” said Vinayak Deshpande, professor of operations and a concentration leader.

The toolkit includes computational tools, predictive and prescriptive models, and statistical methods. The business knowledge encompasses business functions including finance, human resources, marketing, operations and strategy.

As students build their course portfolios, they can hone their data analytic skills across business functions and go deep in selected functions. These skills help students succeed in:

• 
      Traditional business sectors such as retailing, industrial markets, energy, real estate and consumer packaged goods
•     Emerging sectors that include the digital marketplace, fintech, biotechnology and healthcare
•     New ventures that seek to exploit opportunities provided by big data in business-to-consumer and B2B markets

“At UNC Kenan-Flagler we continue to innovate so we can prepare students not only for today’s job market, but also for the future,” said Brad Staats, associate dean of MBA Programs and professor of operations. “With our new STEM-certified concentration we draw on the rich analytical skills across the School and apply them to diverse industries to create unique learning opportunities for our students.”

#

About the University of North Carolina Kenan-Flagler Business School

Consistently ranked one of the world’s best business schools, UNC Kenan-Flagler offers a broad range of programs – Undergraduate, MBA, Master of Accounting, PhD and Executive Development – and extraordinary, real-life learning experiences. Faculty demonstrate unparalleled dedication to students’ learning and a commitment to world-class research that addresses critical business challenges. Contributing to the School’s thought leadership is the Frank Hawkins Kenan Institute of Private Enterprise, which promotes innovative, market-based solutions to vital economic issues. UNC Kenan-Flagler’s collaborative culture is rooted in core values that date back to its founding in 1919, and graduates are renowned as effective, principled leaders with the technical knowledge and leadership skills to deliver results in the global business environment.

Share article on social media or email:

The EVRL Cold Laser in NYC

If it makes my life easier and takes less time to set up, that means more one on one time with patients. That’s not something you see anymore in most practices. That is what sets us apart. We get the patient back to where they want to be, not just back to normal, we help them excel past recovery.

NEW YORK (PRWEB)
December 18, 2019

Dr. Shoshany’s legions of satisfied patients know well how much he likes using lasers as ancillary treatments for pain and injuries. Not satisfied with the three existing hot and cold laser devices, last year Dr. Shoshany added the FX-635 which also holds FDA approval for chronic lower back pain and plantar fasciitis.

While he’s been getting amazing results with the FX-635, Dr. Shoshany also decided to add the latest Erchonia laser, known as the EVRL. What makes this laser unique is it offers red light therapy, which is what most medical laser devices output, but the EVRL also outputs a violet laser frequency. In mathematical terms, the wavelengths are between 4 and 500 nanometers, so it has great applications. The light is also both antimicrobial anti-bacterial.

Patients complaining of neck pain, back pain or even knee pain now have an even easier time undergoing non-invasive treatment. With all these advanced attributes combined, Dr. Shoshany is getting extraordinary results without drugs, and without surgery.

The application of the laser lasts about 3 minutes, so after an adjustment, before undergoing spinal decompression, a provider can quickly use the laser on the neck or back. This allows the use of additional ancillary treatments to help manage pain and speed healing without adding a lot more time to each visit. And the addition of the EVRL is not limited to an already unrivaled class-leading spinal decompression protocol. Violet laser light is not just a colored diode, it operates on a different wavelength, and may demonstrate different recovery properties. When combined with the red laser, we have a new and unique combination not seen before in the field of light therapy. The device’s individually programmable heads put out different frequencies at the same time so several different symptoms can be addressed with the same EVRL device.

When asked about his favorite attribute of the EVRL Laser, Dr. Shoshany says, “I love portability and ease of use. If it makes my life easier and takes less time to set up, that means more one on one time with patients. That’s not something you see anymore in most practices. That is what sets us apart. We get the patient back to where they want to be, not just back to normal, we help them excel past recovery.”

Whether it is simply pain, inflammation, or rotator cuff tendonitis, adding this laser to any treatment protocol can speed a patient’s tissue healing, getting patients back to their routine functional and pain-free quickly. If you’re a patient looking to learn about the new EVRL, or want to learn how Dr. Shoshany and his team integrate the EVRL laser into physical therapy and chiropractic applications, please call us at 212 645 8151.

Share article on social media or email:

NEW YORK (PRWEB)
December 19, 2019

The December 31 use-it-or-lose-it deadline is approaching and millions of flexible spending account (FSA) holders are at risk of forfeiting their hard-earned money. To help, FSAstore.com, the first direct-to-consumer e-commerce destination dedicated to making FSA shopping simple, has compiled its list of best-selling new products from 2019.

Confusion over knowing what products are eligible is one of the most common reasons account holders say they don’t use their funds throughout the year. Everything on FSAstore.com is guaranteed eligible, and having access to lists and ideas can help them get the maximum tax benefit from their accounts and benefit better from their tax-free health dollars.

Whether account holders have $100 or $1,000 left to spend in their FSAs this deadline season, they’ll be amazed by just how many qualified health products their benefit covers. With more than 4,000 products from sun care, baby care and drug-free pain relief, there’s an eligible product to suit any lifestyle. But if you’re looking for some inspiration, the following list of the most-popular new products FSAstore.com added in 2019 is a great place to start.

1. SpotMyUV Detection Stickers

The world’s first clinically-proven UV detection sticker that changes color to let wearers know when it’s time to reapply sunscreen.

2. Aculief Wearable Acupressure for Headache Relief

Drug-free pain relief for headaches that uses acupressure on specific pressure points to relieve pain and tension.

3. Miku Smart Baby Monitor

The Audience Favorite in BabyTech at the 2019 Consumer Electronics Showcase (CES), the Miku is an advanced baby health monitor that uses uses artificial intelligence (AI) and machine learning to track breathing, motion, sleeping patterns, and more.

4. Elvie Electric Breast Pump (Single) (Double)

Pump anywhere, anytime. The Elvie is worn inside a standard nursing bra to provide a hands-free, smartphone-compatible device that sets up in minutes.

5. Caring Mill Select Heat Moist/Dry Heating Pad

Heating pads are a smart buy to treat a wide range of pain issues, including muscle aches, cramps, and arthritis pain. As a special bonus for FSA users, every purchase of a Caring Mill product will benefit Children’s Health Fund, a national nonprofit dedicated to providing health care to underserved youth throughout the United States.

6. MedAngel ONE Wireless Thermometer

For medications that are temperature sensitive, the MedAngel ONE is a smartphone-compatible thermometer designed for extreme environments to notify users if their medication temperature exceeds safe zones.

7. Coola From Beach to Boardroom Tinted Mineral Liplux Trio SPF 30

If a sun protection product is SPF15+ and offers broad-spectrum coverage, it’s FSA-eligible. This product, which comes in three shades, was a customer favorite in 2019.

8. BioWaveGO Wearable Chronic Pain Relief Technology

This TENS machine provides drug-free pain relief in a wearable design to treat a wide range of acute and chronic pain, such as conditions affecting the back, neck, shoulders, and wrists.

9. Omron Complete Wireless Upper Arm Blood Pressure Monitor + EKG

This complete, at-home blood pressure tracking and EKG solution is smartphone compatible and can store up to 90 prior readings for a more complete picture of current health status.

10. Kanjō Travel Acupressure Set

Drug-free relief of neck, back, and foot pain for people on the go. The Kanjō Travel Acupressure Set can reduce pain, tension and discomfort and can easily fit in a carry-on or travel bag.

Use the “2019 FSA Deadline Spending Guide” for hassle-free deadline shopping

The “2019 FSA Deadline Spending Guide” is another way that FSAstore.com makes deadline shopping easy for account holders. The guide features the best bundles, hi-tech health products, and other customer favorites to help account holders find the products they need quickly and worry-free. FSAstore.com has account holders covered this 12/31 deadline with:

• The largest selection of 100% guaranteed FSA-eligible products
• The ability to use FSA debit card and skip the paper claims
• 24/7 access to trusted FSA experts via phone or online chat
• Fast and free shipping on orders over $50
• Accepts all deadline orders until midnight on December 31

About FSAstore.com

FSAstore.com is flex spending with zero guesswork. It’s both the largest online marketplace for guaranteed FSA-eligible products and an educational resource that you can actually understand. It’s the company’s mission to help millions of FSA holders manage and use their accounts, and save on more than 4,000 health items using tax-free funds.

About Health-E Commerce

Health-E Commerce is the parent company of FSAstore.com, HSAstore.com and WellDeserved, a family of brands that serve the 60+ million consumers with pre-tax health and wellness accounts. The company has also created Caring Mill, a popular private-label line of health products that benefits Children’s Health Fund and enables customers to make a donation with each purchase. Since 2010, the company’s brands have led the direct-to-consumer e-commerce market for pre-tax health and wellness benefits. Health-E Commerce plays an essential role in expanding product eligibility for important new categories within the IRS-approved list of eligible medical expenses like sunscreen and breast pumps. The company leads a committee of industry experts to promote the important national conversation around product safety and authenticity.

Share article on social media or email:

Patients as Partners brings together biopharma, patients, advocacy and FDA to demonstrate the impact of engaging with patients throughout the drug development lifecycle to help create better clinical efficiencies and outcomes

NEW YORK (PRWEB)
December 20, 2019

The Conference Forum has announced the keynote speakers for the 7th annual Patients as Partners US event, taking place March 16-17 at the Hilton Philadelphia at Penn’s Landing in Philadelphia, PA.

Opening the 7th annual program is patient keynote, Jeff Borghoff, who will provide personal insights on his experience in the failed Biogen/Eisai Alzheimer’s trial.

Joining the program for the first time is Dr Chip Bell, world-renowned authority on customer loyalty and innovative service, to share tangible examples from the service industry to inspire R&D culture to support service-oriented thinking that brings value back to patients.

Industry keynotes are Dr Joanne Waldstreicher, CMO, Johnson & Johnson, and Dr Darryl Sleep, SVP, Global Medical and CMO, Amgen. They will give a CMO’s perspective on patient-centric research, making the patient experience central to business strategy and building a culture of patient centricity.

Ken Getz, Director of Sponsored Research Programs, Tufts CSDD, returns to the program, sharing new data on patient preferences and experiences to inform patient engagement strategies and tactics.

“Patients as Partners brings together biopharma, patients, advocacy and FDA to demonstrate the impact of engaging with patients throughout the drug development lifecycle to help create better clinical efficiencies and outcomes,” said Kate Woda, Director of Patients as Partners US. “It’s the fastest growing event dedicated to demonstrating how patient engagement and involvement in drug development gets done.”

Four FDA agencies will provide patient engagement guidance updates, new efforts and participate in an FDA Town Hall session, including Anindita Saha, Director of External Expertise and Partnerships (EEP), CDRH; Michelle Tarver, MD, PhD, Director of Patient Science & Engagement, CDRH; Meghana Chalasani, Senior Research Analyst, Office of the Center Director, CDER; Karen Jackler, Patient Engagement Program Manager, CDER and Michael Kopcha, PhD, RPh, Director, OPQ.

As of December 10, 2019, the speaking faculty includes biopharma representation from Amgen, Johnson & Johnson, Genentech, Pfizer, Merck, Sanofi, Janssen, GSK, Takeda, BMS, Sangamo Pharmaceuticals, Biogen and Agios Pharmaceuticals, along with patients and advocates from GO2 Foundation for Lung Cancer, Hereditary Neuropathy Foundation, Parkinson’s Foundation and Huntington’s Disease Youth Organization.

To learn more about the event, please visit Patients as Partners US.

About Patients as Partners US

Patients as Partners US is co-produced with patients, industry, academia, government and nonprofit organizations to establish a well-rounded program that addresses the needs of all stakeholders seeking to implement and advance patient involvement across the entire clinical development continuum.

About the Conference Forum

The Conference Forum is a life science industry research firm which develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused.

Share article on social media or email:

This campaign aims to serve as a guidebook for physicians and healthcare professionals and to highlight technologies that increase the quality of patient care.

NEW YORK (PRWEB)
December 20, 2019

Mediaplanet today announces the launch of this December’s edition of “Connected Health.” This campaign aims to serve as a guidebook for physicians and healthcare professionals and to highlight technologies that increase the quality of patient care.

Healthcare is on the forefront of a digital revolution! With the hopes that patients, providers, payers and physicians will have an open flow of communication in the near future, healthcare will be connected more than ever before in the past. Innovations that utilize everything from artificial intelligence, data, and analytics to virtual reality are creating better health outcomes for the population as whole. Doctors and health systems have been slow to adopt these crucial technologies, but it is key to improving the quality of care that is provided.

The print component of “Connected Health” is distributed within today’s edition of USA Today in Chicago, Los Angeles, San Francisco, Houston, New York, Boston and Washington DC markets, with a circulation of approximately 200,000 copies and an estimated readership of 600,000. The digital component is distributed nationally, through a vast social media strategy, and across a network of top news sites and partner outlets. To explore the digital version of the campaign, visit: https://www.futureofpersonalhealth.com/campaign/connected-health/

Mikhail Varshavski, better known as Dr. Mike graces the cover of the print publication. Through an exclusive interview on the interior, Dr. Mike explains his take on the digital transformation within healthcare. He encourages doctors to utilize social media to interact with patients. “It fosters a very healthy doctor-patient conversation. When patients come into my office after they’ve seen so much of my content, we can start talking about their conditions as if we’ve known each other for much longer than ten minutes.”

Doctor Mike is a board-certified family medicine physician focusing on health education and disease prevention. One of the leading names in medicine on and offline, Doctor Mike has amassed a global following of over eight million subscribers. He advocates for evidence-based healthcare and is active in combating misinformation both online and on television.

This campaign was made possible with the support of HIMMS, Dr. Mike, AHIP, Northwestern University, Trapollo, Total Brain, Savonix, Department of Human and Health Services, Deloitte and Convey Health Solutions.

About Mediaplanet

Mediaplanet specializes in the creation of content marketing campaigns covering a variety of industries. We tell meaningful stories that educate our audience and position our clients as solution providers. Our unique ability to pair the right leaders with the right readers, through the right platforms, has made Mediaplanet a global content marketing powerhouse. Our award-winning stories have won the hearts of countless readers while serving as a valuable platform for brands and their missions. Just call us storytellers with a purpose. Please visit http://www.mediaplanet.com for more on who we are and what we do.

Press Contact:

Lee Hayes             

lee.hayes@mediaplanet.com

(646) 518-5423

Share article on social media or email: